Thank you for your interest in the Cleveland Clinic fellowship program in pulmonary and critical care medicine! As program director, I am immensely proud of our fellows and what we have to offer in terms of a training environment and curriculum as they undertake their journey to becoming specialists in the field. Our program mission statement captures the vision of our program, what we aim to accomplish, and how .
I feel we have a unique setting for learning all aspects of pulmonary and critical care medicine, and I hope you will spend some time on this website or contact us to learn more about how we train our fellows.
We are committed to training physicians with a passion for clinical care, education, and research to become tomorrow's leaders in pulmonary and critical care medicine through excellence in patient care, scholarship, innovation and leadership.
We will accomplish this by:
- Providing world-class patient care and unparalleled clinical training
- Recruiting proactive visionary candidates with a diversity of career goals
- Promoting individualized mentorship
- Supporting, protecting, and guiding meaningful educational and research opportunities
- Innovating in education
- Teaching and role modeling character traits of effective healers and scholars, including communication, integrity, compassion, and teamwork
- Embracing quality and safety as a culture
The Cleveland Clinic is nationally known as a center of innovation, and we love to innovate new ways to enhance the training in our program. We have protected “education days” each month for our fellows, new simulation-based curricula introduced every year for the past several years, and a comprehensive orientation in July including hands-on training in bronchoscopy, ultrasound and bedside ICU procedures.
One of the hallmarks of our program is the flexibility to develop an individualized pathway through training, under the direction of involved and capable mentors. After completing their core requirements for board eligibility, our fellows enjoy the freedom to design a track suited to their career goals and interests, including additional clinical training, research, administrative experience and education. Our institute has ample resources to support virtually any kind of track a fellow might choose, with close to $9 million in research funding and many researchers involved at every level of investigation, including basic sciences, translational, clinical, quality and educational research projects.
Again, we thank you for your interest in our training program and invite you to discover more about it. If you are considering training as a fellow in pulmonary and critical care medicine, we encourage you to apply to our program through ERAS. We would love to show you in person what we are doing here in fellowship education, and how we can help you achieve your professional goals.
Ren Ashton, MD, FACP, FCCP
Facts & Figures
The Respiratory Institute encompasses the Departments of Pulmonary Medicine, Critical Care Medicine, Allergy and Immunology, and Infectious Disease. The Institute has realized enormous growth in the past several years, increasing the size of its faculty to over 150 physicians and expanding beyond the main campus to eight regional hospitals and 10 free-standing outpatient facilities.
Our physicians possess wide-ranging clinical expertise and oversee a number of nationally renowned referral programs serving both common (sarcoidosis, pulmonary vascular disease, lung cancer, interstitial lung disease, asthma, neuromuscular disease) and uncommon (lymphangioleiomyomatosis, hereditary hemorrhagic telangiectasia) disease populations. Outpatient visits approach 55,000 annually.
Our lung transplant program performed 129 transplants in 2017, second in the nation in annual volume of procedures performed. The program commonly transplants patients turned down by other centers.
Members of our Interventional Pulmonology section perform over 4,000 bronchoscopies annually and offer state of the art diagnostic and therapeutic options for patients.
As a testament to our clinical strengths, U.S. News and World Report ranked Cleveland Clinic #3 in the nation for pulmonary services.
Coupled with our clinical initiatives is a thriving research enterprise that encompasses virtually all areas of pulmonary and critical care medicine. Several faculty hold joint appointments in the Lerner Research Institute where they run NIH-funded basic science labs investigating molecular and cellular mechanisms relevant to pulmonary fibrosis, pulmonary hypertension and asthma. Numerous other members of the Respiratory Institute have participated in major NIH-sponsored collaborative clinical trials networks including ARDSNet, Idiopathic Pulmonary Fibrosis Clinical Research Network, Prevention and Early Treatment of Acute Lung Injury (PETAL), Long Term Oxygen Treatment Trial (LOTT) for COPD and the Clinical Trials in Organ Transplantation.
Dr. Wiedemann is Chairman of the Cleveland Clinic Respiratory Institute. He is a graduate of Cornell University College of Medicine and completed residency training in internal medicine at the University of Washington, where he also served as chief medical resident. This was followed by a fellowship in pulmonary and critical care at Yale-New Haven Hospital. Dr. Wiedemann joined the Cleveland Clinic in 1984, assumed the role of Chairman of the Department of Pulmonary, Allergy, and Critical Care in 1991, and with the recent establishment of the Respiratory Institute, became its inaugural Chair. In this role, Dr. Wiedemann has orchestrated the dramatic growth of the Institute faculty, which has more than tripled in size over the past five years and now exceeds 90 members.
Dr. Wiedemann has a long-standing interest in ARDS and has been an active participant in clinical and translational research directly relevant to the treatment of this disorder. Notably, he served as a principal investigator for the NIH-sponsored ARDSnet I and ARDSnet II and was study co-chair of the “Fluids and Catheters Treatment Trial” (FACTT), which demonstrated efficacy of a conservative fluid management strategy in improving lung function and shortening duration of mechanical ventilation and ICU stay. Through his service, frequently as chairman, on the independent monitoring boards of 17 clinical trials related to sepsis and/or ARDS, Dr. Wiedemann gained extensive experience in the design, conduct, and monitoring of clinical trials.
Dr. Wiedemann has authored over 90 original research publications, chapters, and review articles and was the lead editor for three books on acute lung injury. He has served as an ad hoc reviewer for many peer-reviewed publications including New England Journal of Medicine, Annals of Internal Medicine, Chest, European Respiratory Journal, and Journal of Intensive Care Medicine. He is also a former member of the American Board of Internal Medicine Pulmonary Disease Board.
Notable among his recent accomplishments, Dr. Wiederman successfully completed an MBA at Yale while concurrently serving in his role as chair at Cleveland Clinic.
Dr. Kotloff is Chairman of the Department of Pulmonary Medicine at the Cleveland Clinic. He has worked in the field of lung transplantation for nearly 25 years and has extensive clinical experience in the evaluation of transplant candidates and in the care of transplant recipients. In addition to his involvement in lung transplantation, Dr. Kotloff has special expertise in the evaluation and management of patients with lymphangioleiomyomatosis (LAM) and other cystic lung diseases. He also maintains an active interest in general pulmonary medicine and, in particular, in evaluating patients with complex pulmonary disorders.
In addition to his clinical activities. Dr. Kotloff has made medical education and scholarship a focus of his career. He has authored over 100 peer-reviewed articles, review articles, and book chapters and has edited or co-edited four books, including the 5th edition of Fishman's Pulmonary Disease and Disorders. He previously directed the Pulmonary and Critical Care Fellowship Training Program at the University of Pennsylvania for 24 years. He served as Chair of the Pulmonary Disease Test Writing Committee of the American Board of Internal Medicine. He also served as Chair of the Transplant Network of the American College of Chest Physicians and as President of the Association of Pulmonary and Critical Care Medicine Program Directors. He was an Associate Editor of the American Journal of Respiratory and Critical Care Medicine from 2010-2014 and currently is a Section Editor for CHEST. He is the 2011 recipient of the American College of Chest Physicians College Medalist Award recognizing “meritorious service in furthering work in chest medicine.” He is also the 2013 recipient of the American Thoracic Society Assembly on Clinical Problems Educator Award given "in recognition of outstanding clinical and educator expertise and significant contribution to clinical education in pulmonary and critical care."
Cleveland is a vibrant city situated on the southern shore of Lake Erie, with a population of 400,000 within the city proper and over 2 million in the Cleveland metropolitan area.